Research
Major Research Interest: T cell quiescence
T cells are considered as the master guardians that protect our body through distinguishing self and non-self and thereby govern the immune system during a human’s entire lifespan. T cells are fated to firmly maintain the quiescent state prior to activation; however, little is known about the biology and factors that underlie this phenomenon. As immunity is lifetime-regulated by a strict balance between quiescence and activation, deciphering the mechanism of T cells quiescence can provide a cornerstone for developing innovative therapeutics.
For decades, T cell studies have solely focused on 1) activation, 2) differentiation, and 3) effector function. The research efforts have revealed the cell-extrinsic cues such as Signal 1 (cognate antigen through TCR), Signal 2 (co-stimulatory signals), and Signal 3 (stimulatory cytokines) that accounts for the initiation of T cell activation and differentiation. However, this cell-extrinsic mechanism is insufficient to illustrate how most T cells normally sustain quiescence while inhibiting spontaneous activation.
How are the quiescent T cells remained in the poised state and prepared for rapid transition to an activated state?
Which are intrinsic features essential for the maintenance of quiescence?
What does define their threshold for quiescence exit? How are they wired?
How are the quiescent T cells strictly preventing spontaneous activation?
By utilizing genetically modified mice and state-of-the-art immunological and molecular biological techniques with multidisciplinary collaboration, we primarily focus on these questions to find out fundamental mechanisms on the process of quiescence to activation transition in T cells.
Recently, we identified that BTG1/2-mediated intrinsic deadenylation is required for securing T cell quiescence (Science, 2020). This work describes the hitherto unknown mechanism by which quiescent T cells actively sustain the ground state through an intrinsic system prior to activation.
mRNA destabilization by BTG1 and BTG2 secures T cell quiescence
BTG1 and 2 are mainly expressed in naive and memory T cells. We found out that BTG1/2 interact with PABP and the CNOT complex in order to promote mRNA deadenylation and degradation. In this way, BTG1/2 can direct the down-regualtion of mRNAs at global level to restrict mRNA abundance in quiescent T cells. In BTG1/2 conditional knockout mice, total RNA-seq of naive T cells showed a global increase in mRNA abundance in DKO T cells, which allows naive T cells easily to exit from the quiescent state. It infers that mRNA abundance in naive T cells have the proclivity to be up-regulated, but BTG1/2 actively degrade the bulk of cytoplasmic mRNA to maintain quiescent state. This mechanism is seemingly inefficient in terms of cost, but the availability of pre-synthesized mRNA provides a great benefit to quiescent T cells of a rapid response to activation signals. Science (2020) Mar 13;367(6483):1255-1260.
연구방향
1. 본 연구실은 면역 세포가 작동하는 근본적인 원리를 '휴지기'의 관점으로 탐구합니다.
2. 새로운 원리를 바탕으로 다양한 면역질환(암, 자가면역질환, 알러지, 비만 등)의 치료법을 개발하는 것을 목표로 합니다.
본 연구실은 1) 면역학, 2) 분자생물학, 3) 세포생물학, 4) 생화학, 5) 생물정보학을 포함하여 융복합적이고 다면체적인 생물학 연구를 수행합니다.
수행 중인 과제
1. 휴지기 관점에서 T 세포의 운명 재해석
대표논문참조 https://science.sciencemag.org/content/367/6483/1255
2. 면역 질환 모델 연구 (염증질환, 자가면역질환, 알레르기, 당뇨병, 암)
https://www.pnas.org/content/116/51/25790
https://www.pnas.org/content/110/1/276
https://www.nature.com/articles/ncomms10789
3. 유전자가위를 이용한 혁신항암타겟 발굴 (CAR-T, 고형암 치료)
4. 알레르기성 질환 (아토피, 천식) 연구와 치료제 개발
https://onlinelibrary.wiley.com/doi/abs/10.1111/all.13078
https://www.pnas.org/content/107/23/10614
연구분야 키워드
#T cell quiescence
#유전자가위 스크리닝
#감염면역
#만성면역질환
#면역학
#신약타겟 후보 유전자 발굴
#아토피, 천식
#자가면역질환
#항암면역
#후성유전체학